, /PRNewswire/ -- HistoIndex, a global leader in digital pathology solutions for the management of chronic liver disease, is pleased to announce changes to its Scientific Advisory Board (SAB). Established in 2017 under the leadership of the late Dr. , the SAB has played a crucial role in guiding HistoIndex's research and development efforts.
Current members include Prof. , Prof. , Prof.
, and Prof. . Prof.
, a professor of Medicine, Physiology, and Molecular Pathology at (VCU) School of Medicine, has been appointed as the new Chairman of HistoIndex's SAB. Also serving as the Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU, Prof. Sanyal's leadership spans multiple prestigious roles as Chair of the NIH NASH Clinical Research Network, the NIMBLE consortium, and the Liver Forum.
A continuous NIH grant recipient since 1995, Prof. Sanyal brings well over 500 publications in leading journals to the role, placing him in the top 0.1% of biomedical scientists globally.
"I am honored to lead HistoIndex's Scientific Advisory Board," said Prof. Sanyal. Our collective expertise will drive innovative solutions in chronic liver disease management, pushing the boundaries of scientific discovery to improve patient outcomes.
" Prof. Vlad Ratziu, a professor of Hepatology at Sorbonne University and the Pitié-Salpêtrière Hospital in , also joined the SAB. With over 400 publications and an H-index of 96, Prof.
Ratziu is a prominent researcher in steatot.
